Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Sensorineural Hearing Loss in Children with Sickle Cell Disease: A Series of Four Cases

Khalid Elsir Elbashir, Celine Richard, Tomas Bryndziar, Carrie McIvor, Paul T Lavoie, Alyssa Cotton, Ragha Srinivasan, Clifford M. Takemoto, Parul Rai

Blood (2024) 144 (Supplement 1): 5316.

https://doi.org/10.1182/blood-2024-208939

Published: 2024

Journal Articles

A Retrospective Study of First and Recurrent Venous Thromboembolism in Patients with Acute Lymphoblastic Leukemia Treated on Total XV and Total Xvi Protocols

Rohith Jesudas, Justin Kirkham, Tomas Bryndziar, Hiroto Inaba, Timothy Jacobs, Sima Jeha, Victoria Okhomina, Guolian Kang, Cheng Cheng, Clifford M. Takemoto, Ching-Hon Pui, Seth E. Karol

Blood (2024) 144 (Supplement 1): 7707.

https://doi.org/10.1182/blood-2024-210355

Published: 2024

Journal Articles

Thrombolytic Therapy for Venous Thromboembolism in the Pediatric Population: A Systematic Review and Meta-Analysis

Blood (2024) 144 (Supplement 1): 2633.

https://doi.org/10.1182/blood-2024-212166

Published: 2024

Journal Articles

Sickle Cell Disease-Related Worry and Associations with Healthcare Utilization in Youth with Sickle Cell Disease

Alex Pizzo, Guolian Kang, Victoria Okhomina, Jerlym Porter, Jason Hodges, Parul Rai, Clifford M. Takemoto, Jane S Hankins, Nicole M. Alberts

Blood (2024) 144 (Supplement 1): 1065.

https://doi.org/10.1182/blood-2024-202603

Published: 2024

Journal Articles

Impact of Duffy-Null Phenotype on Neutrophil Counts and Clinical Outcomes in Patients with Sickle Cell Disease and without Hydroxyurea

Yan Zheng, Jeffery Gossett, Guolian Kang, Pei-Lin Chen, Clifford M. Takemoto

Blood (2024) 144 (Supplement 1): 1129.

https://doi.org/10.1182/blood-2024-198232

Published: 2024

Journal Articles

Late Venous Thromboembolic Events in Survivors of Childhood Cancer: A Report from the St. Jude Lifetime Cohort Study

Rohith Jesudas, Lei Wang, Yan Chen, Sedigheh Mirzaei, Siddhant Taneja, Kirsten K Ness, Matthew J. Ehrhardt, Stephanie B Dixon, Bonnie Ky, Melissa M. Hudson, Clifford M. Takemoto, Daniel M. Green, Daniel A. Mulrooney

Blood (2024) 144 (Supplement 1): 698.

https://doi.org/10.1182/blood-2024-203521

Published: 2024

Journal Articles

Prospective Genomic Study for Optimizing Clonal Hematopoiesis Surveillance in Bone Marrow Failure Syndromes and Related Cytopenia

Blood (2024) 144 (Supplement 1): 2704.

https://doi.org/10.1182/blood-2024-199328

Published: 2024

Journal Articles

Anticoagulation Therapy for Venous Thromboembolism in the Pediatric Population: A Systematic Review and Meta-Analysis

Blood (2024) 144 (Supplement 1): 1257.

https://doi.org/10.1182/blood-2024-212150

Published: 2024

Journal Articles

Health-Related Communication in Adolescents and Young Adults with Sickle Cell Disease

Tori Langmuir, Guolian Kang, Doralina Anghelescu, Jason Hodges, Jerlym Porter, Keesha Roach, Jane S Hankins, Parul Rai, Clifford M. Takemoto, Nicole M. Alberts

Blood (2024) 144 (Supplement 1): 3688.

https://doi.org/10.1182/blood-2024-202138

Published: 2024

Journal Articles

Vaso-Occlusive Crisis in Patients with Sickle Cell Anemia with Elevated Fetal Hemoglobin

Parul Rai, Rohith Jesudas, Guolian Kang, Clifford M. Takemoto, Yunusa Olufadi, Pei-Lin Chen, Phillip A Doerfler

Blood (2024) 144 (Supplement 1): 5063.

https://doi.org/10.1182/blood-2024-208481

Published: 2024

Journal Articles

Birth-Related Risk Factors Impact Cognitive and Academic Outcomes in Children with Sickle Cell Disease

Jennifer N Longoria, Andrew M Heitzer, Joshua Semko, Halle T McCracken, Erin MacArthur, Guolian Kang, Catherine R Hoyt, Jane S Hankins, Clifford M Takemoto

Blood (2023) 142 (Supplement 1): 5128.

https://doi.org/10.1182/blood-2023-186586

Published: 2023

Journal Articles

Duffy-Null Patients with Sickle Cell Disease Are at Risk for Low Neutrophil Counts with HU Treatment

Yan Zheng, Pei-Lin Chen, Jeffery Gossett, Guolian Kang, Clifford M Takemoto

Blood (2023) 142 (Supplement 1): 1125.

https://doi.org/10.1182/blood-2023-182459

Published: 2023

Journal Articles

The Impact of Socio-Economic Determinants of Health on PedsQL and Pain Outcomes Among Individuals with Sickle Cell Disease

Yogindra Persaud, Victoria Okhomina, Andrew M Heitzer, Hamda Khan, Jason Robert Hodges, Parul Rai, Clifford M Takemoto, Deepika S. Darbari, Guolian Kang, Doralina Anghelescu

Blood (2023) 142 (Supplement 1): 250.

https://doi.org/10.1182/blood-2023-188145

Published: 2023

Journal Articles

Executive Difficulties and Depressive Symptoms Predict Future Acute Pain Emergency Visits and Hospitalizations in Children with Sickle Cell Disease

Andrew M Heitzer, Shuyan Chen, Jennifer N Longoria, Jerlym S. Porter, Guolian Kang, Jane S Hankins, Clifford M Takemoto

Blood (2023) 142 (Supplement 1): 2378.

https://doi.org/10.1182/blood-2023-183016

Published: 2023

Journal Articles

A Genotype Validated Bimodal Method for the Large-Scale Identification and Phenotyping of Persons with Sickle Cell Disease Using Electronic Health Record Data

Kristin Wuichet, Clifford M Takemoto, Robert Cronin, Martha Barton, Pei-Lin Chen, Santosh L. Saraf, Mitchell J. Weiss, Michael R. DeBaun

Blood (2023) 142 (Supplement 1): 7164.

https://doi.org/10.1182/blood-2023-190521

Published: 2023

Journal Articles

Development of a Genetic Risk Score for Albuminuria in Pediatric Patients with Sickle Cell Anemia

Rima Zahr, Guolian Kang, Sara Rashkin, Yutaka Yasui, Csaba Kovesdy, Clifford M Takemoto, Jeffrey D. Lebensburger, Mitchell Weiss, Santosh L. Saraf, Kenneth I. Ataga

Blood (2023) 142 (Supplement 1): 1141.

https://doi.org/10.1182/blood-2023-185213

Published: 2023

Journal Articles

Liposome-Encapsulated Cytarabine and Daunorubicin (CPX-351) Induces Remission in Newly Diagnosed Pediatric Secondary Myeloid Malignancies

Kenneth J Caldwell, Yixin Hu, Mihaela Onciu, Sara M Federico, Marta Salek, Sara Lewis, Shaohua Lei, Jinghui Zhang, Kim E. Nichols, Clifford M Takemoto, Brandon M Triplett, Jason E Farrar, Jeffrey E. Rubnitz, Raul C Ribeiro, Marcin W. Wlodarski

Blood (2021) 138 (Supplement 1): 4415.

https://doi.org/10.1182/blood-2021-149619

Published: 2021

Journal Articles

Associated Co-Morbidities, Healthcare Utilization, and Mortality in Hospitalized Children and Adults with Hemophilia in the United States: Updated Nationally Representative Estimates and a Comparative Analysis

Ashwin Gupta, Abdul Hannan, MD, Ruby Maini, MD, Stephanie Bitner, Pharm D, Schuyler Stone, MD, Manjari Regmi, MD, Aaron Tobian, MD PhD, Cassandra D Josephson, MD, Lakshmanan Krishnamurti, MD, Clifford M. Takemoto, MD, Ruchika Goel, MD MPH

Blood (2019) 134 (Supplement_1): 4711.

https://doi.org/10.1182/blood-2019-123161

Published: 2019

Journal Articles

Improving evidence on anticoagulant therapies for venous thromboembolism in children: key challenges and opportunities

Neil A. Goldenberg, Clifford M. Takemoto, Donald L. Yee, John M. Kittelson, M. Patricia Massicotte

Blood (2015) 126 (24): 2541–2547.

https://doi.org/10.1182/blood-2015-06-651539

Published: 2015

Journal Articles

Mortality Associated with Venous Thromboembolism in Hospitalized Pediatric Patients: A Single Tertiary Care Institute Experience

Raminder Chadha, MS4, Ruchika Goel, MD MPH, Clifford M. Takemoto, MD

Blood (2015) 126 (23): 629.

https://doi.org/10.1182/blood.V126.23.629.629

Published: 2015

NARROW

Sensorineural Hearing Loss in Children with Sickle Cell Disease: A Series of Four Cases

A Retrospective Study of First and Recurrent Venous Thromboembolism in Patients with Acute Lymphoblastic Leukemia Treated on Total XV and Total Xvi Protocols

Thrombolytic Therapy for Venous Thromboembolism in the Pediatric Population: A Systematic Review and Meta-Analysis

Sickle Cell Disease-Related Worry and Associations with Healthcare Utilization in Youth with Sickle Cell Disease

Impact of Duffy-Null Phenotype on Neutrophil Counts and Clinical Outcomes in Patients with Sickle Cell Disease and without Hydroxyurea

Late Venous Thromboembolic Events in Survivors of Childhood Cancer: A Report from the St. Jude Lifetime Cohort Study

Prospective Genomic Study for Optimizing Clonal Hematopoiesis Surveillance in Bone Marrow Failure Syndromes and Related Cytopenia

Anticoagulation Therapy for Venous Thromboembolism in the Pediatric Population: A Systematic Review and Meta-Analysis

Health-Related Communication in Adolescents and Young Adults with Sickle Cell Disease

Vaso-Occlusive Crisis in Patients with Sickle Cell Anemia with Elevated Fetal Hemoglobin

Birth-Related Risk Factors Impact Cognitive and Academic Outcomes in Children with Sickle Cell Disease

Duffy-Null Patients with Sickle Cell Disease Are at Risk for Low Neutrophil Counts with HU Treatment

The Impact of Socio-Economic Determinants of Health on PedsQL and Pain Outcomes Among Individuals with Sickle Cell Disease

Executive Difficulties and Depressive Symptoms Predict Future Acute Pain Emergency Visits and Hospitalizations in Children with Sickle Cell Disease

A Genotype Validated Bimodal Method for the Large-Scale Identification and Phenotyping of Persons with Sickle Cell Disease Using Electronic Health Record Data

Development of a Genetic Risk Score for Albuminuria in Pediatric Patients with Sickle Cell Anemia

Liposome-Encapsulated Cytarabine and Daunorubicin (CPX-351) Induces Remission in Newly Diagnosed Pediatric Secondary Myeloid Malignancies

Associated Co-Morbidities, Healthcare Utilization, and Mortality in Hospitalized Children and Adults with Hemophilia in the United States: Updated Nationally Representative Estimates and a Comparative Analysis

Improving evidence on anticoagulant therapies for venous thromboembolism in children: key challenges and opportunities

Mortality Associated with Venous Thromboembolism in Hospitalized Pediatric Patients: A Single Tertiary Care Institute Experience

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only